"Endpoint Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.
Descriptor ID |
D023381
|
MeSH Number(s) |
E05.315
|
Concept/Terms |
Endpoint Determination- Endpoint Determination
- Determination, Endpoint
- Determinations, Endpoint
- Endpoint Determinations
- End Point Determination
- Determinations, End Point
- End Point Determinations
- Point Determinations, End
Endpoint Assay- Endpoint Assay
- Assay, Endpoint
- Assays, Endpoint
- Endpoint Assays
- End Point Assay
- Assay, End Point
- Assays, End Point
- End Point Assays
- Point Assay, End
- Point Assays, End
|
Below are MeSH descriptors whose meaning is more general than "Endpoint Determination".
Below are MeSH descriptors whose meaning is more specific than "Endpoint Determination".
This graph shows the total number of publications written about "Endpoint Determination" by people in this website by year, and whether "Endpoint Determination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endpoint Determination" by people in Profiles.
-
Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment. Ophthalmology. 2021 08; 128(8):1209-1221.
-
Lobar evenness of deposition/retention in rat lungs of inhaled silver nanoparticles: an approach for reducing animal use while maximizing endpoints. Part Fibre Toxicol. 2019 01 07; 16(1):2.
-
Effect of Alirocumab on Lipoprotein(a) Over =1.5 Years (from the Phase 3 ODYSSEY Program). Am J Cardiol. 2017 Jan 01; 119(1):40-46.
-
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health. 2015 Aug; 3(8):e450-e457.
-
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301). PLoS One. 2012; 7(9):e42322.
-
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLoS Med. 2012; 9(6):e1001236.
-
Defining the potential impact of conjugate bacterial polysaccharide-protein vaccines in reducing the burden of pneumonia in human immunodeficiency virus type 1-infected and -uninfected children. Pediatr Infect Dis J. 2002 May; 21(5):393-9.